142 related articles for article (PubMed ID: 27449261)
61. The effect of androgen supplementation therapy on the prostate.
Kaufman JM
Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497
[TBL] [Abstract][Full Text] [Related]
62. Testosterone for women: necessary or noxious?
Katz A
AWHONN Lifelines; 2006; 10(3):208-9. PubMed ID: 16792707
[No Abstract] [Full Text] [Related]
63. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
Halland A; Jønler M; Pedersen KV
Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
[TBL] [Abstract][Full Text] [Related]
64. Testosterone for women's sexual health disorders: making our voices heard.
Martinez L
AWHONN Lifelines; 2006; 10(3):210-1. PubMed ID: 16862728
[No Abstract] [Full Text] [Related]
65. Re: Testosterone therapy in men with untreated prostate cancer. A. Morgentaler, L. I. Lipshultz, R. Bennett, M. Sweeney, D. Avila, Jr. and M. Khera. J Urol 2011; 185: 1256-1261.
Friedman AE
J Urol; 2011 Oct; 186(4):1559; author reply 1560. PubMed ID: 21907684
[No Abstract] [Full Text] [Related]
66. Testosterone replacement therapy and the risk of prostate cancer: a perspective view.
Barqawi AB; Crawford ED
Int J Impot Res; 2005; 17(5):462-3. PubMed ID: 15889127
[TBL] [Abstract][Full Text] [Related]
67. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
68. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
69. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.
Salman M; Yassin DJ; Shoukfeh H; Nettleship JE; Yassin A
Aging Male; 2017 Mar; 20(1):45-48. PubMed ID: 28084147
[TBL] [Abstract][Full Text] [Related]
70. Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
Barqawi A; Crawford ED
Int J Impot Res; 2006; 18(4):323-8. PubMed ID: 16281043
[TBL] [Abstract][Full Text] [Related]
71. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
72. Testosterone replacement therapy in reversing "andropause": what is the proof-of-principle?
Lang PO; Samaras D; Samaras N
Rejuvenation Res; 2012 Oct; 15(5):453-65. PubMed ID: 22656862
[TBL] [Abstract][Full Text] [Related]
73. Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.
Morgentaler A; Traish AM
Investig Clin Urol; 2020 Jul; 61(4):452-454. PubMed ID: 32666003
[No Abstract] [Full Text] [Related]
74. Anti-aging medicine: hormone replacement therapy in men.
Kaweski S;
Plast Reconstr Surg; 2004 Apr; 113(5):1506-10. PubMed ID: 15060372
[No Abstract] [Full Text] [Related]
75. Testosterone supplementation and the gender divide.
Donovitz GS
Neurourol Urodyn; 2021 Mar; 40(3):938-940. PubMed ID: 33565163
[TBL] [Abstract][Full Text] [Related]
76. Androgens and COVID-19: exploring the role of testosterone replacement therapy.
Punjani N; Flannigan R
Int J Impot Res; 2022 Nov; 34(7):649-651. PubMed ID: 35094017
[No Abstract] [Full Text] [Related]
77. Androgens and women at the menopause and beyond.
Morley JE; Perry HM
J Gerontol A Biol Sci Med Sci; 2003 May; 58(5):M409-16. PubMed ID: 12730248
[No Abstract] [Full Text] [Related]
78. Editorial Comment: Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer.
Javaroni V
Int Braz J Urol; 2022; 48(1):188-195. PubMed ID: 34735092
[No Abstract] [Full Text] [Related]
79. Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.
Anawalt BD
J Clin Endocrinol Metab; 2010 Jun; 95(6):2614-7. PubMed ID: 20525909
[No Abstract] [Full Text] [Related]
80. [Tired, apathetic, weak. Does this man need testosterone?].
Neumaier J
MMW Fortschr Med; 2012 Jul; 154(13):32. PubMed ID: 22957380
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
